# Dianthus Therapeutics Inc. (DNTH) — Operating Income

## Annual Operating Income (USD)

| Year | Operating Income |
| --- | --- |
| 2025 | -$178M |
| 2024 | -$102M |
| 2023 | -$48M |
| 2019 | -$83M |
| 2018 | -$60M |
| 2017 | -$36M |
| 2016 | -$9M |

## Quarterly Operating Income (USD)

| Quarter | Operating Income |
| --- | --- |
| 2025-09-30 | -$40M |
| 2025-06-30 | -$35M |
| 2025-03-31 | -$33M |
| 2024-09-30 | -$30M |
| 2024-06-30 | -$22M |
| 2024-03-31 | -$18M |
| 2023-09-30 | -$16M |
| 2022-09-30 | -$8M |
| 2020-09-30 | -$18M |
| 2020-06-30 | -$20M |
| 2020-03-31 | -$21M |
| 2019-09-30 | -$23M |
| 2019-06-30 | -$19M |
| 2019-03-31 | -$16M |
| 2018-09-30 | -$17M |
| 2018-06-30 | -$14M |
| 2018-03-31 | -$11M |
| 2017-09-30 | -$7M |
| 2017-06-30 | -$16M |

Source: [CompaniesByCap](https://companiesbycap.com/company/DNTH/operating-income)